(Q39692575)

14 September 2017

title

Application of PBPK modelling in drug discovery and development at Pfizer (English)

1 reference

14 September 2017

1 reference

Hannah M Jones

1

1 reference

14 September 2017

Maurice Dickins

2

1 reference

14 September 2017

Kuresh Youdim

3

1 reference

14 September 2017

James R Gosset

4

1 reference

14 September 2017

Neil J Attkins

5

1 reference

14 September 2017

Tanya L Hay

6

1 reference

14 September 2017

Ian K Gurrell

7

1 reference

14 September 2017

Y Raj Logan

8

1 reference

14 September 2017

Peter J Bungay

9

1 reference

14 September 2017

Barry C Jones

10

1 reference

14 September 2017

Iain B Gardner

11

1 reference

14 September 2017

language of work or name

English

0 references

publication date

30 October 2011

1 reference

14 September 2017

1 reference

14 September 2017

volume

42

1 reference

14 September 2017

issue

1

1 reference

14 September 2017

page(s)

94-106

1 reference

Predicting the impact of physiological and biochemical processes on oral drug bioavailability

14 September 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F00498254.2011.627477

Towards a quantitative framework for the prediction of DDIs arising from cytochrome P450 induction

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00498254.2011.627477

Development of physiologically based pharmacokinetic and physiologically based pharmacodynamic models for applications in toxicology and risk assessment.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00498254.2011.627477

Prediction of the disposition of midazolam in surgical patients by a physiologically based pharmacokinetic model

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00498254.2011.627477

Pharmacokinetic predictions in children by using the physiologically based pharmacokinetic modelling

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00498254.2011.627477

Interspecies pharmacokinetic scaling and the evolutionary-comparative paradigm

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00498254.2011.627477

Application of a generic physiologically based pharmacokinetic model to the estimation of xenobiotic levels in human plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00498254.2011.627477

Application of a generic physiologically based pharmacokinetic model to the estimation of xenobiotic levels in rat plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00498254.2011.627477

The prediction of drug metabolism, tissue distribution, and bioavailability of 50 structurally diverse compounds in rat using mechanism-based absorption, distribution, and metabolism prediction tools.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00498254.2011.627477

Prediction of human pharmacokinetics using physiologically based modeling: a retrospective analysis of 26 clinically tested drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00498254.2011.627477

Development and evaluation of a generic physiologically based pharmacokinetic model for children.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00498254.2011.627477

Physiology-based simulations of a pathological condition: prediction of pharmacokinetics in patients with liver cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00498254.2011.627477

Interplay of drug metabolism and transport: a real phenomenon or an artifact of the site of measurement?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00498254.2011.627477

Predictive physiologically based pharmacokinetic model for antibody-directed enzyme prodrug therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00498254.2011.627477

A predictive model of therapeutic monoclonal antibody dynamics and regulation by the neonatal Fc receptor (FcRn).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00498254.2011.627477

Chemical genetics strategy identifies an HCV NS5A inhibitor with a potent clinical effect

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00498254.2011.627477

Evaluation of a basic physiologically based pharmacokinetic model for simulating the first-time-in-animal study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00498254.2011.627477

Membrane transporters in drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00498254.2011.627477

Assessment of algorithms for predicting drug-drug interactions via inhibition mechanisms: comparison of dynamic and static models.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00498254.2011.627477

Development of a PBPK model for monoclonal antibodies and simulation of human and mice PBPK of a radiolabelled monoclonal antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00498254.2011.627477

Utility of in vitro drug metabolism data in predicting in vivo metabolic clearance

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00498254.2011.627477

Prediction of hepatic clearance from microsomes, hepatocytes, and liver slices

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00498254.2011.627477

Prediction of in vivo drug clearance from in vitro data. I: impact of inter-individual variability

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00498254.2011.627477

Physiologically based synthetic models of hepatic disposition

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00498254.2011.627477

Prediction of in vivo drug clearance from in vitro data. II: potential inter-ethnic differences

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00498254.2011.627477

Comparison of the use of liver models for predicting drug clearance using in vitro kinetic data from hepatic microsomes and isolated hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00498254.2011.627477

Prediction of in vivo drug metabolism in the human liver from in vitro metabolism data

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00498254.2011.627477

A framework for assessing inter-individual variability in pharmacokinetics using virtual human populations and integrating general knowledge of physical chemistry, biology, anatomy, physiology and genetics: A tale of 'bottom-up' vs 'top-down' recogn

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00498254.2011.627477

Population-based mechanistic prediction of oral drug absorption

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00498254.2011.627477

A semi-mechanistic model to predict the effects of liver cirrhosis on drug clearance

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00498254.2011.627477

Prediction of the clearance of eleven drugs and associated variability in neonates, infants and children

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00498254.2011.627477

Cytochrome P450 metabolism and inhibition: analysis for drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00498254.2011.627477

Simulation of human intravenous and oral pharmacokinetics of 21 diverse compounds using physiologically based pharmacokinetic modelling

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00498254.2011.627477

Modelling and PBPK simulation in drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00498254.2011.627477

Substrate depletion approach for determining in vitro metabolic clearance: time dependencies in hepatocyte and microsomal incubations

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00498254.2011.627477

Predicting pharmacokinetic food effects using biorelevant solubility media and physiologically based modelling.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00498254.2011.627477

Improving anti-CD45 antibody radioimmunotherapy using a physiologically based pharmacokinetic model.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00498254.2011.627477

Radioimmunotherapy with anti-CD66 antibody: improving the biodistribution using a physiologically based pharmacokinetic model.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00498254.2011.627477

Justification of biowaiver for carbamazepine, a low soluble high permeable compound, in solid dosage forms based on IVIVC and gastrointestinal simulation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00498254.2011.627477

Human clearance prediction: shifting the paradigm

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00498254.2011.627477

Prediction of hepatic metabolic clearance based on interspecies allometric scaling techniques and in vitro-in vivo correlations

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00498254.2011.627477

Use of a physiologically based pharmacokinetic model to study the time to reach brain equilibrium: an experimental analysis of the role of blood-brain barrier permeability, plasma protein binding, and brain tissue binding

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00498254.2011.627477

Prediction of modified release pharmacokinetics and pharmacodynamics from in vitro, immediate release, and intravenous data

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00498254.2011.627477

Evaluation of drug-drug interactions with fesoterodine

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00498254.2011.627477

Pharmacokinetic models of dermal absorption.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00498254.2011.627477

Diffusivity and distribution of vinblastine in three-dimensional tumour tissue: experimental and mathematical modelling.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00498254.2011.627477

Whole body pharmacokinetic models

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00498254.2011.627477

Computer simulations using GastroPlus to justify a biowaiver for etoricoxib solid oral drug products

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00498254.2011.627477

Prediction of the pharmacokinetics of atorvastatin, cerivastatin, and indomethacin using kinetic models applied to isolated rat hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00498254.2011.627477

An evaluation of the utility of physiologically based models of pharmacokinetics in early drug discovery.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00498254.2011.627477

Tissue distribution and physiologically based pharmacokinetics of antisense phosphorothioate oligonucleotide ISIS 1082 in rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00498254.2011.627477

Evaluation of a generic physiologically based pharmacokinetic model for lineshape analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00498254.2011.627477

Prediction of pharmacokinetic profile of valsartan in humans based on in vitro uptake-transport data

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00498254.2011.627477

Prediction of adipose tissue: plasma partition coefficients for structurally unrelated drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00498254.2011.627477

A priori prediction of tissue:plasma partition coefficients of drugs to facilitate the use of physiologically-based pharmacokinetic models in drug discovery.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00498254.2011.627477

Prediction of pharmacokinetics prior to in vivo studies. 1. Mechanism-based prediction of volume of distribution.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00498254.2011.627477

Predicting drug clearance from recombinantly expressed CYPs: intersystem extrapolation factors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00498254.2011.627477

Physiologically based pharmacokinetic modeling 1: predicting the tissue distribution of moderate-to-strong bases.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00498254.2011.627477

Physiologically based pharmacokinetic modelling 2: predicting the tissue distribution of acids, very weak bases, neutrals and zwitterions.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00498254.2011.627477

Mechanistic approaches to volume of distribution predictions: understanding the processes.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00498254.2011.627477

Simulation and prediction of in vivo drug metabolism in human populations from in vitro data

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00498254.2011.627477

Physiologically based pharmacokinetics in drug development and regulatory science: a workshop report (Georgetown University, Washington, DC, May 29-30, 2002).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00498254.2011.627477

Physiologically-based pharmacokinetics in drug development and regulatory science

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00498254.2011.627477

Physiologically based mechanistic modelling to predict complex drug-drug interactions involving simultaneous competitive and time-dependent enzyme inhibition by parent compound and its metabolite in both liver and gut - the effect of diltiazem on th

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00498254.2011.627477

Metabolites in safety testing (MIST): considerations of mechanisms of toxicity with dose, abundance, and duration of treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00498254.2011.627477

Utility of physiologically based pharmacokinetic models to drug development and rational drug discovery candidate selection.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00498254.2011.627477

Application of gastrointestinal simulation for extensions for biowaivers of highly permeable compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00498254.2011.627477

Physiologically based pharmacokinetic model for T84.66: a monoclonal anti-CEA antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00498254.2011.627477

Physiologically based pharmacokinetic modeling to predict transporter-mediated clearance and distribution of pravastatin in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00498254.2011.627477

Circulatory transport and capillary-tissue exchange as determinants of the distribution kinetics of inulin and antipyrine in dog.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00498254.2011.627477

Development of a physiology-based whole-body population model for assessing the influence of individual variability on the pharmacokinetics of drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00498254.2011.627477

A physiologic model for simulating gastrointestinal flow and drug absorption in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00498254.2011.627477

A physiological model for the estimation of the fraction dose absorbed in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00498254.2011.627477

Prediction of oral pharmacokinetics of cMet kinase inhibitors in humans: physiologically based pharmacokinetic model versus traditional one-compartment model.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00498254.2011.627477

A compartmental absorption and transit model for estimating oral drug absorption.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00498254.2011.627477

Applications of physiologically based pharmacokinetic (PBPK) modeling and simulation during regulatory review

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00498254.2011.627477

Prediction of hepatic metabolic clearance: comparison and assessment of prediction models

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00498254.2011.627477

Dissolution testing as a prognostic tool for oral drug absorption: dissolution behavior of glibenclamide

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00498254.2011.627477

10.3109/00498254.2011.627477

21 January 2018

Identifiers

DOI

1 reference

14 September 2017

1 reference